Skip to search formSkip to main contentSkip to account menu

Cytochrome P-450 CYP3A5 Inhibitors

Known as: Inhibitors, CYP3A5, P450 CYP3A5 Inhibitors, CYP3A5 Inhibitors 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
AIM Meta-analyses and large cohort studies provide confusing results on the association of the CYP3A5 6986A>G allelic variant and… 
Review
2012
Review
2012
In the present study, we performed a systematic review and meta-analysis on published data to examine the impact of CYP3A5 6986A… 
Highly Cited
2012
Highly Cited
2012
We evaluated the hypothesis that cytochrome P450 3A5 (CYP3A5) expression can affect intrarenal tacrolimus accumulation… 
2011
2011
El cancer de mama es un problema de salud publica en Mexico y en el mundo. Las enzimas citocromo P450 metabolizan la mayoria de… 
Highly Cited
2011
Highly Cited
2011
AIM Recently a SNP of the gene encoding P450 oxidoreductase (POR*28; rs1057868C>T) has been associated with increased in vivo… 
Highly Cited
2011
Highly Cited
2011
BACKGROUND The effect of potentially relevant genetic polymorphisms, CYP3A5 6986A>G and ABCB1 3435C>T, on Tacrolimus… 
Review
2010
Review
2010
The calcineurin inhibitors ciclosporin (cyclosporine) and tacrolimus are immunosuppressant drugs used for the prevention of organ… 
Review
2010
Review
2010
The calcineurin inhibitors ciclosporin (cyclosporine) and tacrolimus are immunosuppressant drugs used for the prevention of organ… 
Highly Cited
2006
Highly Cited
2006
IntroductionTamoxifen therapy reduces the risk of recurrence and prolongs the survival of oestrogen-receptor-positive patients…